The Spain Radiopharmaceuticals Market growth continues to accelerate as neurodegenerative disease imaging emerges as a critical application for molecular diagnosis of Alzheimer's disease and related dementias. With Spain's aging population and increasing dementia prevalence creating substantial diagnostic demand, the adoption of amyloid PET imaging with Florbetapir, Florbetaben, and Florbetapir...